Anadolu Medical Center
Түркияда жатыр мойны обырын сәулемен емдеу құны әдетте $4,000 мен $8,500 аралығында болады. Емдеудің жалпы құны қажетті сеанс санына, қолданылатын радиациялық технологияға және аурудың кезеңіне байланысты. Түрік клиникаларының стандартты пакеттеріне емдеу жоспарын жасау, барлық сәулелік сеанстар, дәрігер консультациялары және әуежайдан клиникаға дейінгі трансфер кіреді.
Bookimed сарапшысының пікірі: Ыстамбұлда TrueBeam сәулелік емдеу пакетін таңдау өте тиімді. Memorial Şişli және Memorial Bahçelievler секілді JCI аккредитациясы бар ауруханалардағы пакет бағасы 12 550 $ шамасынан басталады. Бұл кешенді қызметтер 30–33 сеансты және әуежай трансферін қамтиды. Мұндай құрылым халықаралық науқастар үшін өте ыңғайлы. Ол 45 күнге созылатын емдеу курсы кезінде күрделі логистикалық мәселелерді шешу қажеттілігін жояды. Memorial Antalya секілді орталықтар 4D-сәулелік терапияны ұсынады, бұл қозғалмалы ісіктерді емдеуде өте жоғары дәлдікті қамтамасыз етеді.
Неге жатыр мойны рагын радиотерапиялау үшін Түркияны таңдаған жөн?
Аккредиттелген клиникаларда жатыр мойны рагын емдеудің озық радиотерапия шешімдерін алыңыз .
| Түркия | Австрия | Испания | |
| Жатыр мойны қатерлі ісігінде сәулелі терапия | бастап $4,000 | бастап $15,000 | бастап $10,000 |
1 күн
Күн 2
Күн 3
Күн 4
Күн 5
Апта 1-4
Апта 5
6 апта
Әр пациенттің қалпына келу үдерісі денсаулығының жеке жағдайына байланысты екенін ескеріңіз.
Доктор Мұстафа Солак Хаджеттепе Университеті және Техас Университетінің MD Anderson Онкологиялық Орталығы сияқты беделді мекемелерде кең көлемді дайындықтан өтіп, әртүрлі қатерлі ісіктерді, соның ішінде жатыр мойны қатерлі ісігін емдеуге маманданған.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Профессор, доктор Шефик Игдем Гайреттепе Флоренс Найтингейл ауруханасында сәулелік терапияның озық әдістеріне маманданған.
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
Success rates for cervical cancer radiotherapy in Turkey reach 98% for five-year overall survival in early-stage cases. Advanced treatments combine external beam radiation with brachytherapy, achieving 86% local control. JCI-accredited centers in Istanbul apply international protocols for stage-specific precision and improved patient outcomes.
Bookimed Expert Insight: Clinical success in Turkey is heavily linked to multidisciplinary collaboration. Experts like Dr. Banu Atalar at Anadolu Medical Center utilize an affiliation with Johns Hopkins Hospital to follow American treatment standards. This partnership ensures that 75% of clinical practice focuses on precise, MR-guided treatments, which explains why top Turkish centers match US survival benchmarks at 77% lower costs.
Patient Consensus: Many patients emphasize the need to verify 3-year and 5-year recurrence rates directly with the clinics. They also recommend planning for a 4-to-6 week stay in Turkey to complete the full radiotherapy course comfortably.
Turkey offers advanced cervical cancer radiotherapy at JCI-accredited centers like Anadolu Medical Center and Memorial Şişli. These facilities utilize precision technologies including MR Linac, TrueBeam STx, and CyberKnife. Expert teams provide multidisciplinary care, integrating IMRT and brachytherapy to target tumors while preserving healthy tissue.
Bookimed Expert Insight: Patient volume data shows Medipol Mega and Anadolu serve over 65,000 to 1 million patients annually. This high traffic often ensures surgeons and physicists have more experience with complex cervical cases. Choose clinics with on-site brachytherapy to avoid external referrals during your treatment phase.
Patient Consensus: Patients emphasize verifying the specific linear accelerator model and physicist qualifications before booking. They also recommend bringing medical imaging on portable media for independent review by local oncologists.
Turkish clinics treat cervical cancer using a synergistic combination of External Beam Radiation Therapy (EBRT) and internal brachytherapy. High-precision technologies like Intensity-Modulated Radiation Therapy (IMRT) and CyberKnife target tumors while protecting surrounding organs. Leading centers in Istanbul and Ankara utilize MRI-guided planning to ensure maximum diagnostic accuracy.
Bookimed Expert Insight: While many countries still rely on standard CT scans, top Turkish facilities like Anadolu Medical Center and Hisar Hospital prioritize PET-CT and MRI-guided planning. This data-driven approach allows surgeons to adapt radiation doses in real-time. This is particularly vital for cervical cases where tumor shape shifts during the 6-week treatment course.
Patient Consensus: Patients emphasize the importance of the combined modality approach, noting that daily EBRT sessions are manageable as outpatients. They frequently highlight the professional coordination required for the 4–5 HDR brachytherapy insertions performed toward the end of treatment.
International patients should plan for a total stay of 8 to 10 weeks in Turkey. This timeline includes 1 to 2 weeks for diagnostic mapping and treatment planning followed by 5 to 7 weeks of active radiation sessions for cervical cancer.
Bookimed Expert Insight: While active treatment finishes in 7 weeks, high-volume centers like Anadolu Medical Center or Memorial Sisli often recommend staying 2 weeks post-therapy. This allows onsite teams to manage acute radiation fatigue or skin sensitivity before you clear a long-haul flight. Starting your digital consultation 4 weeks early can often secure these critical imaging slots before arrival.
Patient Consensus: Patients emphasize that the process is a marathon rather than a sprint. Many advise coordinating with personal clinicial assistants to bundle imaging tests and compress the initial diagnostic window.
Logistical support is not universally standard but is readily available through specialized international patient departments in Turkey. Major oncology centers provide structured assistance including airport-to-hospital transfers, professional medical translation, and hotel coordination to manage the daily hospital visits required for cervical cancer radiotherapy.
Bookimed Expert Insight: While many assume logistics are `all-inclusive,` clinics like Anadolu Medical Center or Memorial often treat these as optional add-ons. You can save significantly by requesting a specific international patient quote that bundles these services before arrival. This approach often secures better rates than self-booking local transport and hotel stays during your 6-week treatment cycle.
Patient Consensus: Patients emphasize the need to confirm every logistical detail via WhatsApp before traveling to Istanbul. Most recommend budgeting extra for daily meals and local travel even when airport transfers are provided.